Skip to main content
. 2023 Oct 4;52(5):111. doi: 10.3892/ijmm.2023.5314

Figure 4.

Figure 4

PPAR, STAT3 and PI3K/Akt signaling pathways and targets of inhibitors against neuroinflammation in AD. PPAR, peroxisome proliferator-activated receptor; AD, Alzheimer's disease; 1, berberine; 2, rice bran extract; 3, telmisartan; 4, bis(ethylmaltolato)oxidovanadium; 5, platycodigenin; 6, (E)-2, 4-bis(p-hydroxyphenyl)-2-butenal; 7, (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol; 8, astaxanthin; 9, stattic; 10, protosappanin A; 11, curcumin; 12, Ent-Sauchinone; 13, sorafenib; 14, DHCR24 (3-β-hydroxysteroid-Δ-24-reductase); 15, sulforaphene; Aβ, amyloid β; LPS, lipopolysaccharide; IKK, IκB kinase; JAK2, Janus kinase; GSK-3β, glycogen synthase kinase-3β; PTEN, phosphate and tensin homolog deleted on chromosome 10.